0,972  0,002  Antiprotozoal
0,966  0,002  Antiprotozoal (Plasmodium)
0,422  0,060  Antineoplastic (lung cancer)
0,361  0,004  Antischistosomal
0,372  0,046  NOS3 expression inhibitor
0,304  0,010  5-Lipoxygenase inhibitor
0,310  0,039  Nitric oxide antagonist
0,329  0,073  Prostate cancer treatment
0,262  0,008  Antifungal (Cryptococcus)
0,364  0,135  Caspase 9 stimulant
0,253  0,030  Antiacne
0,299  0,083  AR expression inhibitor
0,275  0,074  UGT2B4 substrate
0,205  0,005  Lipase inhibitor
0,281  0,090  Antifungal
0,226  0,054  Neurotrophic factor enhancer
0,248  0,084  UGT1A9 substrate
0,247  0,085  Antioxidant
0,254  0,092  GST M1-1 substrate
0,192  0,031  Protein-tyrosine phosphatase 1B inhibitor
0,172  0,013  Contraceptive male
0,200  0,042  Lipid peroxidase inhibitor
0,259  0,101  CTGF expression inhibitor
0,179  0,022  Bronchodilator
0,292  0,136  TNF expression inhibitor
0,242  0,098  Antineoplastic (pancreatic cancer)
0,192  0,050  Protein-tyrosine phosphatase inhibitor
0,264  0,132  GST A substrate
0,302  0,171  Apoptosis agonist
0,181  0,052  Arachidonic acid antagonist
0,174  0,054  Interferon gamma antagonist
0,240  0,126  Antineoplastic (brain cancer)
0,129  0,017  Antiprotozoal activity enhancer
0,190  0,085  Pneumotoxic
0,266  0,163  Antibacterial
0,183  0,085  Sensitization
0,147  0,050  Ca2+-transporting ATPase inhibitor
0,153  0,058  Adenylate cyclase stimulant
0,201  0,106  Cardiovascular analeptic
0,237  0,142  FMO1 substrate
0,180  0,088  UGT1A1 substrate
0,243  0,154  Immunosuppressant
0,171  0,082  Antipruritic, non-allergic
0,119  0,041  Anabolic
0,101  0,023  T cell inhibitor
0,153  0,077  Melanin inhibitor
0,095  0,019  Antitreponemal
0,100  0,026  Antiviral (RSV)
0,184  0,114  NOS2 expression inhibitor
0,164  0,096  Antirickettsial
0,138  0,070  Contraceptive
0,153  0,085  UGT2B7 substrate
0,180  0,114  UGT1A6 substrate
0,155  0,091  UGT2B10 substrate
0,217  0,153  ICAM1 expression inhibitor
0,239  0,176  Antipruritic, allergic
0,096  0,035  Na+ K+ transporting ATPase inhibitor
0,193  0,134  Proliferative diseases treatment
0,106  0,049  UGT2B11 substrate
0,134  0,081  UGT2B15 substrate
0,210  0,157  Antileukemic
0,165  0,115  Antiparasitic
0,139  0,091  UGT2B9 substrate
0,152  0,107  Antihelmintic
0,149  0,107  Lipocortins synthesis antagonist
0,155  0,118  Abortion inducer
0,093  0,056  Triose-phosphate isomerase inhibitor
0,160  0,124  Antineoplastic (glioma)
0,091  0,055  Antidote, mercury
0,127  0,094  SULT1A3 substrate
0,217  0,187  GABA C receptor rho-3 antagonist
0,112  0,086  Alpha-N-acetylglucosaminidase inhibitor
0,030  0,006  Retinoic acid alpha receptor antagonist
0,058  0,035  Pregnane X receptor antagonist
0,024  0,003  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,185  0,165  Tyrosine 3 hydroxylase inhibitor
0,144  0,124  Succinate dehydrogenase inhibitor
0,091  0,072  UDP-glucose 4-epimerase inhibitor
0,104  0,086  Antiviral (CMV)
0,144  0,126  Antineoplastic (glioblastoma multiforme)
0,067  0,053  SULT2A1 substrate
0,025  0,013  Retinoic acid receptor agonist
0,021  0,010  Retinoic acid receptor antagonist
0,055  0,047  Lipocortins synthesis agonist
0,045  0,039  Glucose-6-phosphate isomerase inhibitor
0,058  0,054  Heme oxygenase stimulant
0,109  0,105  Protein kinase stimulant
0,242  0,239  5 Hydroxytryptamine release inhibitor
0,093  0,091  SULT1A1 substrate
0,011  0,010  Retinoic acid beta receptor antagonist
0,010  0,010  Retinoic acid receptor gamma antagonist
0,058  0,058  Phosphofructokinase-1 inhibitor

